Aimei Health Technology Co., Ltd - Ordinary Share (AFJK)
Financial Services › Blank Checks
Price History
Feb 9, 2026 — Aug 17, 2026Investment Snapshot
- P/E of 52.3 — elevated valuation multiple
- Piotroski F-Score 2/9 — signs of financial weakness
- Loss-making — negative ROE of -172.8%
Aimei Health Technology Co., Ltd - Ordinary Share (AFJK) is a Financial Services company operating in Blank Checks, listed on the NASDAQ , with a market capitalisation of $39 million . Key value metrics: P/E ratio 52.3, Piotroski F-Score 2 out of 9 .
Value Score
Key Metrics
Revenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Aimei Health Technology Co., Ltd - Ordinary Share — Fundamental Analysis Summary
Aimei Health Technology Co., Ltd - Ordinary Share (AFJK) trades at a trailing P/E of 52.3x — 181% above the Financial Services sector average of 18.6x.
On financial health, AFJK shows a weak Piotroski F-Score of 2/9, a signal of deteriorating financial health, and negative return on equity of -172.8% (sector average: 5.4%).
StockPik's composite Value Score for AFJK is 25/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
AFJK shows earnings declining at 58%.